Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Gross Margin (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Gross Margin for 6 consecutive years, with 64.98% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin fell 3215.0% year-over-year to 64.98%, compared with a TTM value of 235.78% through Dec 2025, down 3289.0%, and an annual FY2025 reading of 96.86%, up 175.0% over the prior year.
  • Gross Margin was 64.98% for Q4 2025 at Roivant Sciences, down from 92.93% in the prior quarter.
  • Across five years, Gross Margin topped out at 99.47% in Q4 2023 and bottomed at 54.38% in Q3 2021.
  • Average Gross Margin over 5 years is 83.71%, with a median of 90.41% recorded in 2021.
  • The sharpest move saw Gross Margin tumbled -11489bps in 2021, then skyrocketed 2845bps in 2023.
  • Year by year, Gross Margin stood at 81.53% in 2021, then decreased by -3bps to 78.97% in 2022, then rose by 26bps to 99.47% in 2023, then dropped by -2bps to 97.13% in 2024, then tumbled by -33bps to 64.98% in 2025.
  • Business Quant data shows Gross Margin for ROIV at 64.98% in Q4 2025, 92.93% in Q3 2025, and 92.9% in Q2 2025.